Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.24.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
JN.1.18.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.59EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LG.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.75 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.100 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.44 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.50.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.3.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.3.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.65.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDVEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
MK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.42.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-2361.24South Korea
KP.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDV.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.48.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LF.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LB.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used